Oxidized tyrosine (O-Tyr) has attracted more interest in recent years because many researchers have discovered that it and its product (dityrosine) are associated with pathological conditions and metabolic disorders, especially various age-related disorders in biological systems. However, biochemical responses of an organism to short-term O-Tyr and dityrosine (Dityr) administration are unclear.
Introduction
Food proteins are vulnerable to being oxidized during the handling, processing, cooking and storage of food materials.
1,2
The oxidation of proteins leads to a variety of physicochemical modications including protein unfolding and denaturation, cleavage of peptide bonds, formation of cross-links, and loss of functionality.
3 Particularly, specic amino acid side chains are susceptible to oxidation, leading to various chemical modi-cations such as loss of sulydryl groups and amino groups, the formation of carbonyl compounds and other oxidation derivatives. 4, 5 Formation of oxidized protein products in the food system has been proven to cause a signicant decrease in protein nutritional value in terms of availability of essential amino acids and digestibility of oxidized proteins. 2, 5, 6 Furthermore, consumption of oxidized protein products may have adverse health effects.
7-10
Tyrosine (Tyr) is sensitive to various reactive oxygen species (ROS) and other free radicals, leading to formation of oxidized tyrosine (O-Tyr) derivatives (dityrosine, 3-nitrotyrosine, AOPPs, 3-chlorotyrosine, and 3,4-dihydroxyphenylalanine).
11, 12 These derivatives have been widely detected in food systems, and suggested as promising biomarkers for oxidative damage to proteins. [13] [14] [15] [16] [17] Our past ndings have shown that dietary O-Tyr could induce oxidative stress, inammation, hepatic brosis, and renal brosis in rats. 18, 19 Moreover, our previous experiments also provide proof that Dityr (accounting for 22% of the total O-Tyr material) may be responsible for O-Tyr-induced injury. 19 What's more, our study also found that dityrosine exposure impairs hippocampus-dependent non-spatial memory accompanied by modulation of NMDA receptor subunits and expression of brain-derived neurotrophic factor (Bdnf).
20
Traditional studies on O-Tyr and Dityr administration have been performed by measuring and comparing a single or several biochemical markers. However, these studies did not sufficiently reect the overall metabolic status of animals or humans exposed to O-Tyr and Dityr. Therefore, a holistic investigation of the systemic metabolic effects of O-Tyr and Dityr on a whole living bio-system is required to better understand the relationship between O-Tyr administration, Dityr administration, and human health.
Metabonomics, a powerful top-down systems biological tool based on proton nuclear magnetic resonance ( 1 H NMR) spectroscopy or mass spectrometry techniques, together with multivariate statistical analysis methods, provides an effective method for evaluating metabolic responses of living organisms to nutritional intervention. 21, 22 1 H NMR spectroscopy is one of the major techniques used in metabolomic studies as the spectra of biouids or tissues contain a wealth of metabolic information and provide novel insight into the intervention effect or perturbation of diets with regard to nutrient metabolism and health.
23 On the basis of 1 H NMR analysis, Stella et al. 24 applied an NMR-based metabonomic approach for characterization of the metabolic effects of vegetarian, low meat, and high meat diets in humans. This study illustrates the efficacy of the metabonomic approach for measuring inuence of dietary modulations on short-term human metabolism. He et al. 25 reported that dietary arginine administration alters the catabolism of fat and amino acids in the whole body, enhances protein synthesis in skeletal muscle, and modulates intestinal microbial metabolism in growing pigs using a 1 H NMR technique. A 1 H NMR-based metabonomic approach was also applied to evaluate global metabolic responses to L-tryptophan, cysteamine, spermine, chlorogenic acid, green tea and black tea, pea ber and wheat bran ber, and drinking water administration in animals. [26] [27] [28] [29] [30] [31] [32] 18, 19, 35 Chemical structures of tyrosine, dityrosine and 3-nitrotyrosine are shown in Fig. 1 . ELISA kits of advanced oxidized protein products (AOPPs), Dityr and 3-nitrotyrosine (3-NT) were purchased from Xiamen Huijia Bioengineering Institute (Xiamen, China). Detection kits for total antioxidant capacity (T-AOC), malondialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), reduced glutathione (GSH) and oxidized glutathione (GSSG) were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). All chemicals used in the experiments were analytical grade.
Materials and methods

Materials
Animal experiments and sample collections
All animal experimental procedures were performed according to the National Guidelines for Experimental Animal Welfare (MOST of PR China, 2006), and approved by the Jiangnan University Institutional Animal Care and Use Committee. Female Kunming mice weighing approximately 25 g (4 weeks old) were purchased from Suzhou University (Suzhou, China). A total of 30 mice were housed in a SPF animal laboratory, and kept at a constant temperature of 22 AE 2 C and relative humidity of 50 AE 10% with a 12/12 h light/dark cycle. Aer acclimatization for one week, mice were randomly divided into three groups (n ¼ 10): the control group (gavage administration of physiological saline solution once daily for 7 days), the O-Tyr group (gavage administration of O-Tyr once daily for 7 days), and the Dityr group (gavage administration of Dityr once daily for 7 days). O-Tyr and Dityr were dissolved in physiological saline solution and gavage administered at a dose of 320 mg kg À1 body weight, respectively. The dosages of O-Tyr and Dityr for this study were selected based on previous reports from our laboratory. [18] [19] [20] All mice were given free access to the same standard diet and drinking water throughout the study. The mice diet was conducted according to the general quality standard for formula feeds of laboratory animals in China (GB14924. 1, 2001 ).
Urine samples were collected from each mouse into icecooled vessels from day 6 to day 7 of the treatment period (24 h) . At the end of the experimental period, all mice were sacriced aer an overnight fast. Blood samples were collected (10:00-11:00 a.m.) from eyeballs under anesthesia (intraperitoneal injection of sodium pentobarbital), placed into Eppendorf tubes, kept at 4 C for 30 min, and centrifuged at 3500g for 15 min at 4 C to obtain serum. All urine and serum samples were stored at À80 C until ready for NMR spectroscopy analysis. Liver and kidney tissues from each group were immediately collected for subsequent analysis.
Analysis of oxidative damage and total antioxidant capacity
The concentrations of AOPPs, Dityr, and 3-NT in liver and kidney were assayed using kits and following manufacturer's instructions. The activity of T-AOC, CAT, SOD, and GSH-PX, and the concentration of GSH, GSSG, and MDA in serum, liver, and kidney also were assayed using kits and following manufacturer's instructions.
Assay of mRNA expression related in antioxidant enzymes
For determining mRNA expression, total RNA was rst extracted from frozen tissues with Trizol reagent. The amount and purity of the RNA were veried by measuring the A260/A280 ratio and gel electrophoresis, respectively. 
37,38
Data processing for metabonomic analysis Subsequently, all remaining regions of the spectra were normalized to the total integrated area of the spectra to reduce any signicant concentration differences before multivariate data analysis. Normalized NMR datasets were exported to TXT les using Mestrenova 6.1.1 soware, imported into Microso Office Excel 2007 (Microso Corporation, Redmond, Washington, USA) for integration, and then imported into the soware package SIMCA-P 13.0 (Umetrics, Umea, Sweden) for multivariate data analysis. Initially, in a unsupervised manner, principal component analysis (PCA) was performed on the dataset to generate an overview and identify possible outliers within the dataset. 39 Each point in the score plots represented an individual spectrum of a sample. If one point position was outside the Hotelling's T 2 ellipse on the score plot, it was removed from the dataset. Subsequently, partial latent structure-discriminate analysis (PLS-DA) was conducted to distinguish experimental group mice and control group mice in a supervised manner.
The quality of the model was evaluated by the parameters: R 2 X (representing the total explained variation) and Q 2 (standing for the model predictability). R 2 > 0.50 and Q 2 > 0.50 indicates that the model is robust and has good tness and prediction. Leaveone-out cross validation and the response of the permutation test (200 cycles) should be used to evaluate the reliability of the model when a small number of samples is adopted. Furthermore, a supervised pattern recognition approach known as an orthogonal projection to latent structures discriminant analysis (OPLS-DA) was used to improve classication of the different groups while screening biomarkers. With an aim to discover potential variables contributing to the differentiation, we generated an S-plot for the OPLS-DA model used to dene metabolites signicantly contributing to the separation of the two groups. 40 Metabolites with VIP (variable importance in the projection) values $1.0 were regarded as signicant in this study. VIP is a computation of the inuence of every X term in the model on the Y variable. Larger VIP values indicate a greater inuence of a term X on the Y variable. 41 Meanwhile, an independent sample t-test was further used to validate those major contributing variables from the PLS-DA and OPLS-DA models using the soware of SPSS 17.0 (SPSS Inc., Chicago, USA). Values of P < 0.05 were regarded as signicant statistical signicance. Only those metabolites that meet the two criteria are eventually considered as potential biomarkers.
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Fig. 3 Effects of O-Tyr and DT administration on MDA (A) content, T-AOC (B), CAT (C), SOD (D) and GSH-PX (E) activity, and GSH/GSSG value (F)
in mice serum, liver and kidney. Data from each group (n ¼ 10) were averaged and presented as means AE SEM. P values <0.05 were regarded as significant statistical significance. 
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Statistical analysis
All other experimental results were also statistically analyzed using the soware of SPSS 17.0. Statistical signicance was determined by a one-way analysis of variance (ANOVA) followed by the Tuckey post hoc test. 43 Data were presented as mean AE standard error of the mean (SEM). P values less than 0.05 were accepted as statistically signicant.
Results
Effects of O-Tyr and DT administration on body weights in mice
Effects of O-Tyr and DT administration on the body weight of mice are listed in Table 2 . At the beginning of the study, the body weights of mice in the O-Tyr group and DT group were the same as in the control group. At the end of the experiments, OTyr and DT administration had a tendency to decrease the body weights of mice, but there were no statistically signicant differences between the three groups (P > 0.05).
Effects of O-Tyr and DT administration on protein oxidation of mice liver and kidney
Effects of O-Tyr and DT administration on the concentrations of AOPPs, Dityr and 3-NT in mice liver and kidney are shown in Fig. 2 . Compared with control group, O-Tyr administration signicantly increased the concentration of AOPPs in liver, and the concentrations of Dityr and 3-NT in kidney (P < 0.05). DT administration signicantly increased the concentration of AOPPs in liver, and the concentrations of AOPPs and Dityr in kidney (P < 0.05).
Effects of O-Tyr and DT administration on the antioxidant capacity of mice serum, liver, and kidney Effects of O-Tyr and DT administration on T-AOC, CAT, SOD, and GSH-PX activity, and GSH/GSSG and MDA content in mice serum, liver, and kidney are shown in Fig. 3 . O-Tyr administration signicantly decreased the activity of T-AOC in serum and GSH-PX in liver, and reduced the value of GSH/GSSG in liver, and increased the content of MDA in serum and liver, compared to the control group (P < 0.05). DT administration signicantly decreased the activity of T-AOC in serum, and declined the activity of SOD in serum and liver, decreased the activity of GSH-PX in serum, liver, and kidney and reduced the value of GSH/GSSG in serum, liver, and kidney, and increased the content of MDA in serum, liver, and kidney (P < 0.05). Table 3 . in Fig. 4 . Quantitative RT-PCR analysis showed that O-Tyr administration signicantly reduced the antioxidant enzyme of GSH-PX expression in liver and kidney tissues (P < 0.05). DT administration signicantly decreased the antioxidant enzymes of SOD1, SOD2 and GSH-PX expressions in liver tissue, and declined the antioxidant enzyme of GSH-PX expression in kidney tissue (P < 0.05).
Effects of O-
1 H NMR spectra of urine and serum samples Tables 3 and 4 , respectively. The spectra of serum samples contained resonances from several amino acids, short-chain fatty acids, nitrogenous compounds, acetyl glycoproteins, lipoproteins, glucose, ketones, TCA cycle intermediates, and choline metabolites. The urine samples mainly contained several amino acids, glucose, organic acids, allantoin, TCA cycle intermediates, short-chain fatty acids, nitrogenous compounds, and metabolites of amino acids, choline, and vitamin B 3 . In order to obtain more details about metabonomic changes in OTyr and DT group mice, multivariate data analyses were further conducted on 1 H NMR data for serum and urine.
Multivariate data analysis of 1 H NMR data
1 H NMR spectral data sets from serum and urine were initially analyzed by PCA. The PCA score plots of serum and urine ( Fig. 7A and 8A , respectively) showed there were no outliers within the dataset, and separations were absent in the metabolic serum and urine proles of mice from the control group, O-Tyr group, and DT group. Therefore, PLS-DA was applied to explore the intrinsic differences between these three groups.
Samples from different groups were separated and classied into three distinct clusters presented in the PLS-DA score plot ( Fig. 7B and 8B, respectively) . The model parameters (serum: 
and the validated models (permutation number: 200) indicated no over tting (Fig. 7C and 8C ), respectively. All the results indicated the existence of differences between the three groups. Furthermore, spectral data sets from serum and urine were analyzed by OPLS-DA to maximize discrimination between the three groups ( Fig. 7D and F and 8D and F) , respectively. The supervised model of OPLS-DA could develop a better separation into two clusters and contribute to the discovery of biomarkers. The O-Tyr group and DT group were well separated from the control group in the OPLS-DA scores plot of spectral data sets from serum and urine, as well as in permutation tests and variance analysis of the cross-validated residuals (CV-ANOVA) (P < 0.05), respectively. Metabolites responsible for a signicant contribution to separation of the two groups are indicated in the corresponding S-plots (Fig. 7E and G and 8E and G) and marked with a number. The VIP statistics of the rst principal component of OPLS-DA model (threshold $ 1), together with the Pvalue of the independent sample t-test (threshold < 0.05) were used for selecting signicant variables responsible for group separation. 52 The identied potential markers in serum and urine are listed in Tables 5 and 6 , respectively. O-Tyr administration signicantly increased the serum levels of propionate, isobutyrate, 3-hydroxybutyrate, acetoacetate, citrate, methylamine and choline, and decreased the serum levels of isoleucine, valine and a-glucose compared with the control group (P < 0.05, Table 5 ). Moreover, O-Tyr administration signicantly increased the urine levels of acetoacetate, pyruvate, succinate, allantoin, N 1 -methyl-4-pyridone-5-carboxamide (4-PY), N 1 -
) and corresponding Splot (E and G) based on the methyl-2-pyridone-5-carboxamide (2-PY), m-hydroxyphenylacetate, N-methylnicotinamide and trigonelline compared with the control group (P < 0.05, Table 6 ). Dityr administration signicantly increased the serum levels of propionate, isobutyrate, 3-hydroxybutyrate, acetoacetate, citrate, trimethylamine, choline and GPC, and decreased the serum levels of isoleucine, valine, alanine, betaine and aglucose compared with the control group (P < 0.05, Table 5 ). Also, DT administration signicantly increased the urine levels of acetoacetate, pyruvate, succinate, citrate, allantoin, 4-PY, 2-PY, m-hydroxyphenylacetate, nicotinamide N-oxide and trigonelline, and decreased the urine levels of p-hydroxyphenylacetate and hippurate compared with the control group (P < 0.05, Table 6 ).
Discussion
Tyrosine (Tyr) is one of the major targets of protein oxidation; oxidation products of Tyr (such as Dityr and 3-NT) are universal biomarkers of protein oxidation and have been demonstrated to be associated with metabolic disorders in biological systems.
18
In this study, 1 H nuclear magnetic resonance spectroscopy was used to demonstrate the effects of O-Tyr and Dityr administration on metabolomes in the serum and urine of mice. Our results support the hypothesis that O-Tyr and Dityr administration can cause systemic metabolic alterations in serum and urine (Tables 5 and 6 , respectively). O-Tyr and Dityr administration induced oxidative stress responses in mice. Ketone bodies, such as acetoacetate and 3- hydroxybutyrate, are the products of b-oxidation of fatty acids in mitochondria. 53, 54 Increased serum acetoacetate and 3-hydroxybutyrate levels suggested that O-Tyr and Dityr administration promoted b-oxidation of fatty acids. The ratio of acetoacetate to 3-hydroxybutyrate is a useful indicator of the mitochondrial redox state.
55 O-Tyr and Dityr administration were found to increase the urinary level of acetoacetate, but the concentration of 3-hydroxybutyrate in urine remained unchanged. As a result, acetoacetate/3-hydroxybutyrate ratios were increased, respectively. These results further suggest a highly oxidized cell state, which can be brought about by increased oxidation of fatty acids. Lipid oxidation can generate large amounts of electrons entering a mitochondrial respiratory chain to produce excess reactive oxygen species (ROS), 56 thereby causing free radical oxidative damage. 57, 58 Oxidative stress followed by lipid oxidation is believed to be an important cause of destruction and damage to cell membranes. 59 In support of this theory, O-Tyr administration increased the serum level of choline while DT administration increased the serum levels of choline and GPC, and decreased the level of betaine compared with the control group. Choline and GPC are essential for structural integrity of the cell membrane. 60, 61 These compounds also have important functions in cell metabolism and signaling processes.
62,63
Oxidation of choline in liver mitochondria results in the formation of betaine. 64, 65 Some studies have shown that betaine functions to spare choline for the formation of phospholipids. 66, 67 In the present study, serum levels of choline and GPC were increased and betaine was decreased. A possible explanation is that structural integrity of the cell membrane was decreased.
Moreover, O-Tyr and Dityr administration induced elevation of urinary allantoin, which is an end product of the oxidation of uric acid by purine catabolism; this result also supports enhanced oxidative stress in agreement with previous studies that considered the elevation of urinary allantoin as an indicator for oxidative stress. 68, 69 Furthermore, elevation of urinary 4-PY, and 2-PY in mice administration with O-Tyr, and the elevation of urinary nicotinamide N-oxide, 4-PY, and 2-PY in mice administration with Dityr suggested that metabolisms of nicotinate and nicotinamide (vitamin B 3 ) were probably associated with progression of oxidative stress. Nicotinamide is a component of nicotinamide adenine dinucleotide (NAD) involved in intracellular respiration to oxidize fuel substrates, 70 while nicotinamide N-oxide, 4-PY, and 2-PY are oxidation metabolites of nicotinamide in liver. 44 Past research found that increased levels of nicotinamide N-oxide, 4-PY, and 2-PY imply elevated oxidative stress response in vivo.
71 Therefore, the changes of these nicotinamide metabolites are probably also indications that O-Tyr and Dityr administration can induce oxidative stress responses in mice.
What's more, oxidative stress ultimately triggers an antioxidative response in an organism. Trigonelline and N-methylnicotinamide are the respective methylated metabolites of nicotinate and nicotinamide, which can be generated during the conversion of S-adenosylmethionine to Sadenosylhomocysteine during biosynthesis of cysteine, an essential amino acid of glutathione synthesis.
51,72 A previous report suggests that elevated levels of N-methylnicotinamide and decreased levels of nicotinate indicate increased oxidative stress response in vivo. 73 In our study, the elevation of urinary trigonelline and N-methylnicotinamide in mice administration with O-Tyr, and the elevation of urinary trigonelline in mice administration with Dityr, implied that mice can utilize an antioxidative vitamin B 3 cycle to decrease oxidative stress induced by O-Tyr and Dityr administration. The observation of an increased level of m-hydroxyphenylacetate, also implies antioxidative responses activated by O-Tyr and Dityr administration. This is because m-hydroxyphenylacetate is a rutin metabolite and an antioxidant.
74
Taken together, O-Tyr and Dityr administration induced oxidative stress responses in mice. The increased levels of AOPPs, Dityr, 3-NT, and MDA (as markers of protein and lipid oxidative injury), decreased activities of T-AOC, SOD, and GSH-PX, and declined antioxidant enzymes mRNA expression of SOD1, SOD2, and GSH-PX, also supports such a theory ( Fig. 2  and 3 ). Moreover, this is in agreement with results from our previous study that 24 week exposure to O-Tyr induces oxidative damage in rats.
18,19
A novel and unexpected nding from this study was that OTyr and Dityr administration promoted energy metabolism. OTyr and Dityr administration signicantly decreased serum aglucose levels compared with the control group. Glucose is a major substrate for energy metabolism. The decreased levels of a-glucose in serum suggested that O-Tyr and Dityr administration promoted glycolysis. Moreover, Dityr administration decreased serum alanine levels. Alanine is an important participant and regulator in glucose metabolism. 75 Taken together, Dityr administration enhanced the glucose-alanine cycle metabolism. What's more, the observation of increased levels of pyruvate in urine suggested that O-Tyr and Dityr administration led to a promotion of the TCA cycle. This is because pyruvate is a key metabolite that is important in both glycolysis and the TCA cycle, and can be converted into acetylCoA by decarboxylation and transported into the TCA cycle under aerobic conditions. 76 Increased pyruvate levels revealed that generation of acetyl-coenzymeA (acetyl-CoA) was upregulated, resulting in promotion of the TCA cycle. In support of this view, O-Tyr signicantly increased serum citrate levels, and urine succinate levels, and Dityr administration signi-cantly increased serum citrate levels, and urine citrate and succinate levels. Citrate and succinate are important intermediates of the TCA cycle. A change in the contents of citrate and succinate would reect a change in the metabolic rate of the TCA cycle. 77, 78 Increased levels of citrate and succinate in serum and urine suggests that the TCA cycle is promoted by administration with O-Tyr and Dityr. Our results also showed that levels of branched-chain amino acids were decreased by O-Tyr and Dityr administration. A possible reason is that oxidative stress-induction increased energy expenditure and also caused elevated consumption of amino acids, such as isoleucine, alanine, and valine, to provide energy.
Another novel and unexpected nding from this study was that O-Tyr and Dityr administration caused changes in gut microbiota functions. Previous research from our group has shown that oxidized casein administration induced a decrease of intestinal Lactobacillus and increased intestinal Escherichia coli and Enterococcus in mice. 79 Intestinal microbes convert dietary non-digestible bers into short-chain fatty acids (acetate, propionate, butyrate, and isobutyrate) and other nutrients that can be used by the mammalian host as energy sources or as precursors for fatty acid synthesis. 80 In this study, we found that O-Tyr and Dityr administration signicantly increased serum propionate and isobutyrate levels, implying that O-Tyr and Dityr administration caused changes in gut microbiota functions. In support of this theory, serum levels of methylamine in the O-Tyr group and trimethylamine in the Dityr group were increased compared with the control group. Serum nitrogenous compounds (methylamine, dimethylamine, trimethylamine, and TMAO) are microbial metabolites of carbohydrates and amino acids, which are probably produced in the lumen of the small and large intestines. 23, 81 Hippurate is one of the co-metabolites between gut microbiota and a host, and is a product of the conjugation of glycine and benzoic acid, 82 which takes place in mitochondria of the liver and kidney. 83, 84 Benzoic acid is a product of the intestinal microbial degradation of aromatic compounds in food. [85] [86] [87] Therefore, a change in the excretion of hippurate suggests an alteration in the functional metabolism of microbiota. 88 In this study, we found a marked elevation in the levels of hippurate in the urine of mice administration with Dityr; this result also supports the view that Dityr administration changes intestinal microbial metabolism. Moreover, p-hydroxyphenylacetate is a metabolite of tyrosine processed by enteric bacteria. Decreased levels of phydroxyphenylacetate in urine also conrmed the association of Dityr administration with a gut microbiota disturbance.
In this work, changes in these metabolites of intestinal microora may be explained by an increased number and/or altered activity of intestinal microora. Mammalian metabolism is signicantly inuenced by interactions with the complex gut microbiota. An introduction of O-Tyr and Dityr ingestion into the mammalian system may displace baseline mammalianto-microbial behavior, thereby disrupting microbial populations and eventually affecting metabolism. Gut microbiota signicantly affect development and structure of the intestinal epithelium, digestive and absorptive properties of the intestine, and the host immune system. 89 Possible disturbances of gut microbiota by O-Tyr and Dityr administration can affect health; thus, microbiological identication of specic changes in the microbiota community can help address metabolic implications of O-Tyr and Dityr administration.
Conclusions
This study has shown that O-Tyr and Dityr administration affects the urine and serum metabolome of mice. O-Tyr and Dityr administration can cause oxidative stress and some common systemic metabolic changes, including energy metabolism, glucose-alanine cycle metabolism, glycolysis, cell membrane metabolism, vitamin-B 3 metabolism, and gut microbiota metabolism. Therefore, we need additional intake of antioxidant and vitamin-B 3 when much more oxidative proteins are ingested. These results are very important for animal and human food safety and disease prevention. To the best of our knowledge, this study is the rst in vivo report on the response of animal biological systems to O-Tyr and Dityr administration. Future studies may be directed toward a mechanistic understanding of the effects of O-Tyr and Dityr on animal tissue intermediary metabolism, especially in terms of the associations between deciency of B vitamins and O-Tyr and Dityr administration.
